. . "Special k"@en . "Ketamina"@en . "(\u00B1)-ketamine"@en . . . . . . . "2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone"@en . . "2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone"@en . . "6740-88-1"@en . . "2-(methylamino)-2-(2-chlorophenyl)cyclohexanone"@en . . . . . "Humans and other mammals"@en . . . . . "A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (receptors, N-methyl-D-aspartate) and may interact with sigma receptors. [PubChem]"@en . "John A. Flores, Kenton L. Crowley, \"Process for the preparation of ketamine ointment.\" U.S. Patent US5817699, issued June, 1995."@en . "Ketamine"@en . . "NMDA"@en . "KETAMINE"@en . "Rapidly absorbed following parenteral administration."@en . "# Harrison NL, Simmonds MA: Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex. Br J Pharmacol. 1985 Feb;84(2):381-91. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2858237 # Bergman SA: Ketamine: review of its pharmacology and its use in pediatric anesthesia. Anesth Prog. 1999 Winter;46(1):10-20. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10551055 # Bonanno FG: Ketamine in war/tropical surgery (a final tribute to the racemic mixture). Injury. 2002 May;33(4):323-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12091028 # Lankenau SE, Sanders B, Bloom JJ, Hathazi D, Alarcon E, Tortu S, Clatts MC: First injection of ketamine among young injection drug users (IDUs) in three U.S. cities. Drug Alcohol Depend. 2007 Mar 16;87(2-3):183-93. Epub 2006 Sep 18. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16979848 # Reboso Morales JA, Gonzalez Miranda F: [Ketamine] Rev Esp Anestesiol Reanim. 1999 Mar;46(3):111-22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10228376"@en . "Ketaminum"@en . " "@en . . . . . . . . "DL-ketamine"@en . . . . . . . . . . . . . . . . . "approved"@en . . . . . . "Ketamine has several clinically useful properties, including analgesia and less cardiorespiratory depressant effects than other anaesthetic agents, it also causes some stimulation of the cardiocascular system. Ketamine has been reported to produce general as well as local anaesthesia. It interacts with N-methyl-D-aspartate (NMDA) receptors, opioid receptors, monoaminergic receptors, muscarinic receptors and voltage sensitive Ca ion channels. Unlike other general anaesthetic agents, ketamine does not interact with GABA receptors."@en . . " "@en . . . "2.5-3 hours."@en . . . . . . . . . . . . . . . . . . "For use as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation."@en . "(+-)-Ketamine"@en . . . . . . . .